Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis
article
OA: green
CC0
⤵ 76 in-corpus citations
AI-generated summary
This paper reports on the clinical effects of the levonorgestrel-releasing intrauterine device in patients diagnosed with adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Adenomyosis: via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Danazol Suspension Injected into the Uterine Cervix of Patients with Adenomyosis and Myoma via openalex
- Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation via openalex
- Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography. via openalex
- Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis via openalex
- Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system via openalex
- The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up via openalex
- The nonsurgical diagnosis of adenomyosis via openalex
- Therapeutic options for adenomyosis: a review via openalex
- The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis via openalex
- Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis via openalex
- Transvaginal ultrasound for diagnosis of adenomyosis: a review via openalex
- Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device via openalex
- Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology via openalex
- Uterus and endometrium: The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation via openalex
- W2327042378 via openalex
- W159019070 via openalex
- W1971184127 via openalex
- W2015334359 via openalex
- W2042374015 via openalex
- W2043601943 via openalex
- W2048097238 via openalex
- W2053998452 via openalex
- W2057022929 via openalex
- W2069437409 via openalex
- W2081101461 via openalex
- W2085449376 via openalex
- W2093975594 via openalex
Cited by (50)
- Effects of Leuprorelin combined with Mirena on endocrine function, emotion, quality of life, and endometrial receptivity in patients with adenomyosis 2025
- Efficacy of levonorgestrel intrauterine system in conservative management of abnormal uterine bleeding: an emerging tool 2025
- Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis 2024
- Contraception et adénomyose 2024
- Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal 2024
- Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence 2024
- Suture fixation of the levonorgestrel-releasing intrauterine device with hysteroscope for the treatment of adenomyosis in patients at high risk of device expulsion 2023
- Association Between Uterine Volume and In Vitro Fertilization (IVF) Reproductive Outcomes of Infertile Patients with Adenomyosis 2023
- Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - A Systematic Review 2023
- Suture-fixation of a levonorgestrel-releasing intrauterine device under hysteroscopic guidance 2023
- Histopathological characteristics of adenomyosis: structure and microstructure 2023
- The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up 2023
- Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis 2023
- Evaluation of Levonorgestrel-Releasing Intrauterine System (LNG) in The Management of Uterine Adenomyosis: An Update Systematic Review and Meta- Analysis 2023
- Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up 2022
- Diagnosis and Surgical Management of Adenomyosis 2022
- Ultrasound-guided transvaginal radiofrequency ablation combined with levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyosis treatment 2021
- Benign gynecologic lesions 2021
- Non-contraceptive Benefits of Hormonal Methods 2021
- A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis 2021
- Laparoscopic adenomyomectomy combined with l<scp>evonorgestrel‐releasing</scp> intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness 2020
- Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis 2020
- Ulipristal acetate use in adenomyosis: A randomized controlled trial 2020
- Current and Future Medical Therapies for Adenomyosis 2020
- The efficacy of medical treatment for adenomyosis after adenomyomectomy 2020
- Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified–warmed embryo transfer outcomes in women with adenomyosis 2019
- A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis 2019
- Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis 2019
- Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis 2019
- [Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis]. 2019
- Clinical efficacy of adenomyomectomy using “H” type incision combined with Mirena in the treatment of adenomyosis 2019
- Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis 2019
- Adenomyose 2019
- High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up 2019
- Therapeutic efficacy of Mirena in gynecologic disease 2019
- LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN ADENOMYOSIS; PREDICTORS FOR RESPONSE AND CLINICAL OUTCOME 2018
- Adenomyose 2018
- Minimally invasive treatment of adenomyosis 2018
- Endometriosis and adenomyosis 2018
- Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up 2018
- Experience of Symptoms and Disease Impact in Patients with Adenomyosis 2017
- Long-Term Vaginal Danazol Treatment in Fertile Age Women with Adenomyosis 2017
- Adenomyosis: a systematic review of medical treatment 2016
- Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis 2016
- Adenomiosis: tratamiento 2015
- Effects of Levonorgestrel-Releasing Intrauterine System on Lymphangiogenesis of Adenomyosis 2015
- Levonorgestrel-releasing intrauterine system versus low-dose combined oral contraceptive for treatment of adenomyosis uteri: a randomized clinical trial 2015
- Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial 2015
- 17β-Estradiol Induces Overproliferation in Adenomyotic Human Uterine Smooth Muscle Cells of the Junctional Zone Through Hyperactivation of the Estrogen Receptor-Enhanced RhoA/ROCK Signaling Pathway 2015
- Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition 2015
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:42.556217+00:00
License: CC0
· commercial use OK